Literature DB >> 29567301

Corrigendum to "Pharmacotherapy for NASH: Current and emerging" [J Hepatol 68 (2017) 362-375].

Monica A Konerman1, Jacob C Jones2, Stephen A Harrison3.   

Abstract

Entities:  

Year:  2018        PMID： 29567301     DOI： 10.1016/j.jhep.2018.03.002

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  1 in total

1.  Fufang Zhenzhu Tiaozhi Capsule Prevents Intestinal Inflammation and Barrier Disruption in Mice With Non-Alcoholic Steatohepatitis.

Authors:  Tian Lan; Tonghao Xu; Yanfang Fu; Shuo Jiang; Xiaolin Liang; Ze Yu; Linyu Pan; Xianglu Rong; Jiao Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-16       Impact factor: 6.055
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.